← All trials
NCT03406832
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 8, 2018
- Primary completion
- Dec 31, 2018
- Completion date
- Dec 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhengzhou UniversityLead sponsor
- Zhengzhou UniversityReponsible party - principal investigator
- Zhengzhou UniversityOverall official - principal investigator
- Henan Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Anyang Regional HospitalCollaborator
- Henan University of Traditional Chinese MedicineCollaborator
- Jincheng People’s HospitalCollaborator
- Kaifeng Central HospitalCollaborator
- Lushan People’s HospitalCollaborator
- Nanyang Central HospitalCollaborator
- Puyang Oil Field General HospitalCollaborator
- Puyang People's HospitalCollaborator
- Shenma Medical Group General HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
- Xinxiang Medical UniversityCollaborator
- The First People's Hospital of ShangqiuCollaborator
- The First People's Hospital of XinmiCollaborator
- The First People's Hospital of ZhumadianCollaborator
- The Peoples' Hospital of Jiaozuo CityCollaborator
- The second people's Hospital of JiyuanCollaborator
- The Second People's Hospital of PingdingshanCollaborator
- Xinyang Central HospitalCollaborator
- Yanshi People’s HospitalCollaborator
- Yellow River Sanmenxia hospitalCollaborator
- Zhengzhou Cardiovascular HospitalCollaborator
- Zhoukou Central HospitalCollaborator
- Zhumadian Central HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.